Ras Rap1 Signaling Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ras/Rap1 Signaling Neurons are neuronal populations in which the Ras and Rap1 GTPases play dominant roles in regulating synaptic plasticity, learning, memory, and neuronal survival. These small GTPases serve as molecular switches that control intracellular signaling cascades critical for cognitive function and vulnerable to degeneration in Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders.
The Ras family of small GTPases includes over 20 members in humans, with Ras (HRAS, KRAS, NRAS) and Rap1 (RAP1A, RAP1B) being the most extensively studied in the nervous system [1]. These proteins cycle between an active GTP-bound state and an inactive GDP-bound state, regulated by guanine nucleotide exchange factors (GEFs) that promote activation, and GTPase-activating proteins (GAPs) that accelerate GTP hydrolysis [2].
In neurons, Ras and Rap1 signaling controls:
Ras proteins are 21 kDa GTP-binding proteins that transmit extracellular signals from receptor tyrosine kinases (RTKs) to downstream effectors [3]:
Rap1 (Regulator of Proliferation and Cell Adhesion) has distinct but overlapping functions with Ras [4]:
| Protein | Function | Neuronal Role |
|---|---|---|
| SOS1/2 | Ras/Rap1 GEF | Activity-dependent LTP |
| NF1 | Ras GAP | Synaptic plasticity, learning |
| SPRED1/2 | Ras/Rap1 inhibitor | MAPK regulation |
| CREB | Transcription factor | Gene expression, memory |
Ras/Rap1 signaling is essential for both long-term potentiation (LTP) and long-term depression (LTD) [5]:
LTP Induction:
LTD Induction:
The Ras-RAF-MEK-ERK pathway regulates actin cytoskeleton dynamics in dendritic spines [6]:
The Ras/MAPK pathway couples synaptic activity to nuclear gene expression [7]:
Ras/Rap1-expressing neurons are enriched in:
Ras/MAPK signaling is dysregulated in AD brains [8]:
Therapeutic Implications:
Ras/Rap1 signaling alterations in PD [9]:
Therapeutic Implications:
Germline mutations in Ras pathway genes cause neurodevelopmental disorders [10]:
These disorders highlight the critical role of Ras signaling in cognitive function.
| Drug | Target | Clinical Status | Neurodegeneration Potential |
|---|---|---|---|
| Selumetinib | MEK1/2 | Approved (cancer) | Clinical trials (AD) |
| Tipifarnib | Farnesyltransferase | Approved (cancer) | Preclinical |
| Lonafarnib | Farnesyltransferase | Approved (progeria) | Preclinical |
The study of Ras Rap1 Signaling Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Page updated: 2026-03-07
Ye X, et al. Ras signaling in neuronal development and function. Cell Mol Neurobiol. 2014;34(4):463-472. DOI:10.1007/s10571-014-0130-0 ↩︎
Kim IJ, et al. Ras signaling in learning and memory. Nat Rev Neurosci. 2008;9(9):680-688. DOI:10.1038/nrn2438 ↩︎
Castellano E, Santos E. Functional specificity of Ras isoforms: so similar but so different. Genes Cancer. 2011;2(3):216-231. DOI:10.1177/1947601911408088 ↩︎
Raaijmakers JH, Bos JL. Specificity of Ras-Rap signaling: families, effectors and pathways. Cold Spring Harb Perspect Biol. 2011;3(11):a008912. DOI:10.1101/cshperspect.a008912 ↩︎
Zeng M, et al. Phase separation of Ras/MAPK signaling revealed by synthetic inclusions. Cell. 2020;183(5):1471-1484.e20. DOI:10.1016/j.cell.2020.11.024 ↩︎
Kennedy MB, et al. Signaling mechanisms regulating neuronal morphogenesis. Cell. 2022;185(14):2564-2581. DOI:10.1016/j.cell.2022.06.018 ↩︎
Benarroch EE. Ras-ERK signaling: role in brain function and disease. Neurology. 2018;91(10):451-458. DOI:10.1212/WNL.0000000000006552 ↩︎
Giraldo E, et al. Ras-MAPK pathway dysfunction in Alzheimer's disease. J Alzheimers Dis. 2018;64(2):357-368. DOI:10.3233/JAD-180233 ↩︎
Cookson MR. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci. 2020;21(10):516-527. DOI:10.1038/s41583-020-0354-7 ↩︎
Tidyman WE, Rauen KA. The RASopathies: developmental syndromes involving Ras/MAPK signaling. Curr Opin Genet Dev. 2021;69:23-32. DOI:10.1016/j.gde.2021.01.004 ↩︎